Skip to Content

Vincristine Sulfate Injection

Last Updated: January 31, 2020
Status: Resolved

Reason for the Shortage
    • Pfizer had vincristine on shortage due to manufacturing delays and increased demand. They are the sole supplier of vincristine sulfate injection. There is a Dear Healthcare Professional letter available at https://www.fda.gov/media/131865/download.
    • Teva discontinued Vincosar in early-July 2019.
Available Products
    • Vincristine injection, Pfizer, 1 mg/mL, 1 mL vial, 1 count, NDC 61703-0309-06
    • Vincristine injection, Pfizer, 1 mg/mL, 2 mL vial, 1 count, NDC 61703-0309-16

Estimated Resupply Dates

    • Pfizer has vincristine 1 mg/mL 1 mL and 2 mL vials available.

Updated

Updated January 31, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 1, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide